![](https://i0.wp.com/torontohpbfellowship.com/wp-content/uploads/2020/01/Faiyaz_Notta_Steven_Gallinger-300x169.jpg?resize=300%2C169)
Dr. Faiyaz Notta, (L) scientist with the Princess Margaret Cancer Centre and Ontario Institute for Cancer Research (OICR), and Dr. Steven Gallinger, surgical oncologist at the Princess Margaret, led a team which identified a specific alteration that drives a very aggressive subtype of pancreatic cancer. (Photos: UHN)